1Libby E Inflammation in atheroselerosis [J]. Nature, 2002, 420(6917): 868-874.
2Hansson G K. Inflammation atherosclerosis and coronary artery disease [J]. N Engl J Med, 2005, 352(16):1685-1695.
3Harrington L E, Hatton R D, Mangan P R, et al. Interleukin 17-producing CD4 effecter T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005,6 (11):1123-1132.
4Acos ta-Rodriguez E V, Napolitani G, Lanzavecchia A, et al. Inter-leukins 1 beta and 6 but not transforming growth factor beta are essential for the differentiation of interleukinl7- producing human T helper cells [J]. Nat Immunol, 2007, 8(9): 942- 949.
5Lubberts E, Joesten L A, Oppers B, et al. IL-l-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis [J].J Immunol,2006, 167(8): 1004-1013.
6Aggarwal S, Ghilardi N, Xie M H, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production ofmterleukin-17[J]. J Biol Chem, 2003, 278(3):1910-1914.
7Ouyang W, Kolls J K, Zheng Y. The biological functions oft helper 17 cell effector cytokines in inflammation[J]. Im- munity, 2008, 28(4): 454-467.
8Kolls J K, Lind6 n A. Interleuldn-17 family members and inflammation [J]. Immunity, 2004, 21(4):467-476.
9Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines[J]. J Exp Med, 1996, 183(6):2593- 2603.
10de Boer O J, Becker A E, van der Wal A C. Lymphocytes in athero-genesis-functional aspects and antigenic repertorire[J].Cardiovasc Res, 2003, 60(1):78-86.
2Steinman R M, Cohn Z A. Identification of a novel cell type in pe- ripheral lymphoid organs of mice. I. Morphology, quantitation, tis- sue distribution [ J ]. J Exp Med, 1973,137 ( 5 ) : 1142 - 62.
3Galkina E, Ley K. Immune and inflammatory mechanisms of ath- eroselerosis [ J]. Annu Rev Immunol,2009,27 ( 1 ) : 165 - 97.
4Aukrust P, Otterdal K, Yndested A, et al. The complex role of T- cell-based immunity in atherosclerosis [ J ]. Curr Atheroscler Rep, 2008,10(3) :236 -43.
5Bettelli E, Korn T, Kuchroo V K. Th17 :the third member of the effector T cell trilogy [ J]. Curr Opin Immunol,2007,19 (6) :652 -7.
6Niessner A, Sato K, Chaikof E L, et al. Pathogen-sensing plas- macytoid dendritic ceils stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha [ J ]. Circulation, 2006,114 ( 23 ) :2482 - 9.
7Ohnmacht C, Pullner A, King S B, et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T ceils and results in spontaneous fatal autoimmunity [ J ]. J Exp Med, 2009,206 ( 3 ) :549 -59.
8Xie J J, Wang J, Tang T T, et al. The Th17/Treg functional im- balance during atherogenesis in ApoE (-/-) mice [ J ]. Cytokine, 2010,49(2) :185 -93.
9Zhou L, Littman D R. Transcriptional regulatory networks in Th17 cell differentiation [ J]. Curr Opin Immunol, 2009,21 ( 2 ) : 146 - 52.
10Nishihara M, Ogura H, Ueda N, et al. IL-6-gp130-STA33 in T ceils directs the development of IL-17 + Th with a minimum effect on that of Treg in the steady state [ J ]. Int Immunol,2007,19 (6) : 695 - 702.
